Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veltuzumab Phase I/II in CD20+ Non-Hodgkin's Lymphoma
NCT00596804Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Mar 2004
- Primary completion
- Nov 2007
- Modality
- IgG Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of veltuzumab in non-Hodgkin lymphoma (NHL), sponsored by Gilead Sciences. Started Mar 2004; status: completed.
02
Drugs
veltuzumab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00596804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00596804.